Biotechnology and Bioengineering · 2022 · 22 citations · 16 references
EngineeringBiomedical EngineeringOncologyBiomemsTissue EngineeringTumor MicroenvironmentAngiogenesisCell Culture MicrosystemsMicrofluidic Device FabricationMicrofluidic DevicesMicrofluidic SystemsMicrofluidicsCancer Metastasis MechanismsMicrofluidic Cell CultureMicrofluidic Chip DesignMicrofluidic Culture SystemsMicrofluidic Device DesignSpheroid CultureSpheroid Culture ModelsSpheroid Models
The development of a scalable and highly reproducible in vitro tumor microenvironment (TME) platform still sheds light on new insights into cancer metastasis mechanisms and anticancer therapeutic strategies. Here, we present an all-in-one injection molded plastic array three-dimensional culture platform (All-in-One-IMPACT) that integrates vascularized tumor spheroids for highly reproducible, high-throughput experimentation. This device allows the formation of self-assembled cell spheroids on a chip by applying the hanging drop method to the cell culture channel. Then, when the hydrogel containing endothelial cells and fibroblasts is injected, the spheroid inside the droplet can be patterned together in three dimensions along the culture channel. In just two steps above, we can build a vascularized TME within a defined area. This process does not require specialized user skill and minimizes error-inducing steps, enabling both reproducibility and high throughput of the experiment. We have successfully demonstrated the process, from spheroid formation to tumor vascularization, using patient-derived cancer cells (PDCs) as well as various cancer cell lines. Furthermore, we performed combination therapies with Taxol (paclitaxel) and Avastin (bevacizumab), which are used in standard care for metastatic cancer. The All-in-One IMPACT is a powerful tool for establishing various anticancer treatment strategies through the development of a complex TME for use in high-throughput experiments.
16
Sangeeta N. Bhatia, Donald E. Ingber · Nature Biotechnology · 2014 · 3.2K citations
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations
Medicine, Immunology, Oncology +17
Key cost drivers of pharmaceutical clinical trials in the United States
Aylin Sertkaya, Hui–Hsing Wong, Amber Jessup et al. · Clinical Trials · 2016 · 411 citations